制药收入云
药品收入云帮助制造商在商业化过程中的每个点最大化收入。
探索药物解决方案- 公司
公司
Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical device, high tech, manufacturing and semiconductors across more than 120 countries, including Pfizer, AstraZeneca, Sanofi, Gilead, Abbott, Stryker, AMD, Micron, Seagate, STMicroelectronics, NXP, Sesotec, and Southern States.
- 右块
联系销售
- 公司
公司
Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical device, high tech, manufacturing and semiconductors across more than 120 countries, including Pfizer, AstraZeneca, Sanofi, Gilead, Abbott, Stryker, AMD, Micron, Seagate, STMicroelectronics, NXP, Sesotec, and Southern States.
- 右块
- 公司
公司
Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical device, high tech, manufacturing and semiconductors across more than 120 countries, including Pfizer, AstraZeneca, Sanofi, Gilead, Abbott, Stryker, AMD, Micron, Seagate, STMicroelectronics, NXP, Sesotec, and Southern States.
- 右块
- 行业
- 收入云解决方案
收入云解决方案
N Model Novenue Cloud拥有100个国家 /地区的50,000多名用户，正在实现Pharma，MedTech和High Tech的业务转型，结果令人难以置信。
N模型收入云使组织能够通过优化整个价格瀑布的收入来消除收入泄漏，增加收入并提高利润率
增加最高收入
通过主动管理影响定价和收入的流程来增加最高收入。
消除收入泄漏
通过统一流程和解决方案来积极管理价格瀑布，从而消除收入泄漏。
提高利润率
通过创建设置，分析和优化定价并查看结果的连续性来提高利润。
2 - 3％
将最高收入增加2-3％
3％
将利润率提高3％
5％
消除回扣和奖励多付5％
最大化收入增长和盈利能力
